This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Cj Healthcare Corporation. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: **Innovator Spotlight: Gyong Sik Ha**
Introduction
Gyong Sik Ha is a notable inventor based in Suwon-si, South Korea. With his expertise in biochemistry and pharmaceutical development, he has made significant contributions to the field of biotechnology, specifically focusing on the purification of therapeutic proteins.
Latest Patents
Gyong Sik Ha holds a patent for a method of purifying darbepoetin alfa. This invention, titled "Method for purifying darbepoetin alfa," relates to selectively separating a specific structural isoform that has a high content of sialic acid from a mixture containing various isoforms of darbepoetin alfa. The innovative approach offers a convenient and straightforward process for purification, which not only enhances productivity due to improved process efficiency but also ensures the provision of high-purity darbepoetin alfa during mass production.
Career Highlights
Gyong Sik Ha is currently affiliated with CJ Healthcare Corporation, a prominent player in the healthcare industry. His work is instrumental in developing new methodologies that can lead to higher yield and purity of important pharmaceutical compounds, gaining recognition within the scientific community for his contributions to drug development processes.
Collaborations
Throughout his career, Gyong Sik Ha has collaborated with talented individuals in his field, including notable coworkers Yoon Jung Lee and Kyung Hwa Kim. Their collaboration underscores the importance of teamwork in achieving innovative solutions in healthcare and biotechnology.
Conclusion
Gyong Sik Ha’s relentless pursuit of innovative purification methods exemplifies the spirit of invention in the biopharmaceutical industry. His patent not only contributes to improved production techniques but also enhances the overall quality of therapeutic proteins, showcasing his valuable role within CJ Healthcare Corporation and the broader field of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile